Raut Chandrajit P, Ashley Stanley W
Department of Surgery, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA.
J Gastrointest Surg. 2008 Sep;12(9):1592-9. doi: 10.1007/s11605-008-0501-3. Epub 2008 Mar 4.
The surgical management of gastrointestinal stromal tumors (GISTs) has been impacted by the development of tyrosine kinase inhibitors (TKIs), advances in surgical technique, and a better understanding of the natural history of this unique disease. In this article, we review the technical aspects of the operations, the expanding role of laparoscopy, and the indications for neoadjuvant and neoadjuvant TKI therapy in primary GIST. Furthermore, we explore the rationale for and incorporation of surgery in the multidisciplinary management of advanced GIST.
酪氨酸激酶抑制剂(TKIs)的发展、手术技术的进步以及对这种独特疾病自然史的更好理解,都对胃肠道间质瘤(GISTs)的外科治疗产生了影响。在本文中,我们回顾了手术操作的技术方面、腹腔镜检查作用的扩大以及原发性GIST中新辅助和辅助TKI治疗的适应证。此外,我们探讨了晚期GIST多学科管理中手术的基本原理及纳入情况。